CENTIVAX
CENTIVAX
Industry:
Biotechnology Health Care Health Diagnostics Medical
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.centivax.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Aidar Health
Aidar Health is a healthcare technology and digital therapeutics company.
NMMC
North mississippi medical centre is an medical centre providing acute diagnostic and therapeutic services
Oncology Hematology Care
Oncology Hematology Care provides immunotherapy, medical oncology, radiation, hormone therapy, cancer screenings & nurse navigator services.
PT Diagnos Laboratorium Utama
Diagnos Lab is a health servicer that provides blood tests, pharmaceutical warehouses, blood & sperm banks & other medical support services.
Current Employees Featured
Official Site Inspections
http://www.centivax.com Semrush global rank: 8.76 M Semrush visits lastest month: 261
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Centivax"
Centivax - Crunchbase Company Profile & Funding
Centivax may be growing as indicated by the appointment of a new chief medical officer, which suggests an investment in leadership to drive the company's strategic initiatives. Additionally, โฆSee details»
Centivax Company Profile 2024: Valuation, Funding & Investors
Centivax General Information Description. Developer of a universal vaccine platform intended to treat and eradicate rapidly mutating pathogens. The company applies its computational โฆSee details»
Portfolio โ Centivax
Universal Vaccines: Our first universal vaccine has completed pre-clinical development in ferrets, pigs, mice, rats and human immune organoids, and is scheduled for human clinical trials to begin in 2025. It was awarded a Gates โฆSee details»
Centivax - LinkedIn
Centivax's Chief Executive Officer, Jacob Glanville, said, "We are thrilled to announce BioCina as our Master Cell Bank manufacturing partner for the first phase of manufacturing our universal ...See details»
Centivax Company Profile: Overview and Full News Analysis
Oct 9, 2024 Centivax focuses on the Biotechnology sector. Explore the world of Startups and Venture Investing at OurCrowd.See details»
Centivax, Inc. - BIO International Convention 2024
Jun 3, 2024 Centivax is a broad-spectrum vaccine platform technology company. Founded by leading experts in pharmaceutical development, immunology, vaccine science, computational โฆSee details»
Centivax - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Centivax. โฆSee details»
Centivax CEO Jacob Glanville: "Weโre in the Vaccine โฆ
Dec 16, 2022 In Part II of an exclusive GEN Edge interview, Glanville discusses why Centivax waited to apply its platform to COVID-19; the companyโs $10 million seed financing and future financing plans; and ...See details»
Centivax, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Centivax was initially a therapeutics spinout of Distributed Bio, a contract research organization. Earlier this year, Glanville sold Distributed Bio, to Charles River Laboratories for $83 million in โฆSee details»
Wide Shot: Jacob Glanville Pursues Broad-Spectrum โฆ
Dec 15, 2022 In an exclusive interview with GEN Edge, Centivax CEO and president Jacob Glanville, PhD, discusses Centivaxโs effort to develop broad-spectrum vaccines for mutating viruses, and the challenges ...See details»
Biotechnology Company Centivax Officially Launches - PR Newswire
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad-spectrum โฆSee details»
Centivax Selects Global CDMO BioCina to Initiate cGMP โฆ
Oct 9, 2024 ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), โฆSee details»
Jacob Glanville - Wikipedia
Jacob Eli Gunn Glanville is an American computational immunoengineer and businessperson. He is co-founder and chief executive officer of the start-up company Distributed Bio [1] and its โฆSee details»
Centivax - genengnews.com
May 18, 2020 In January 2020, Distributed Bio spun out Centivax, a company focused on developing the universal vaccine and COVID-19 therapeutics as part of a portfolio that also โฆSee details»
Centivax and U.S. Naval Medical Research Center Announce โฆ
SAN FRANCISCO, June 2, 2021 /PRNewswire/ -- Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for โฆSee details»
Centivax Selects Global CDMO BioCina to Initiate cGMP โฆ
Oct 9, 2024 Centivax is a universal vaccine platform technology company founded and led by experts in vaccinology, vaccine regulatory affairs, immunology, and computational โฆSee details»
Charles River Labs Acquires Antibody Partner Distributed Bio for โฆ
Jan 5, 2021 In January 2020, Distributed Bio spun out Centivax, a company focused on developing the universal vaccine and COVID-19 therapeutics as part of a portfolio that also โฆSee details»
Universal Vaccines, Universal Anti-venom and Broadly Neutralizing ...
Nov 9, 2022 Centivax has developed a broad-spectrum vaccine technology to focus immune responses on conserved parts of these otherwise mutating viruses, resulting in broadly โฆSee details»
Hacking the Immune Response: Novel Vaccine Design to Combat โฆ
Mar 10, 2021 In this GEN webinar, our distinguished speaker Dr. Jacob Glanville, CEO and president of Centivax, will present data on computational immunology interrogation of the โฆSee details»